CYP2C19*1

Navigate to...

Relationships shown below are based on (1) prescribing information, (2) drug label annotations, (3) clinical annotations, (4) variant annotations, or (5) pathways found in PharmGKB. The type of supporting information is indicated below each related pair.

Molecules

Haplotype

CYP2C19*1

and

Chemical

lafutidine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

methylphenobarbital

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

desmethyl clomipramine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

normeperidine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

androstenedione

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

3-cyano-7-ethoxycoumarin

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

icotinib

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

phenazepam

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

carisoprodol

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

tolperisone

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

brivaracetam

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

famotidine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

dipyrone

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

cilostazol

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

ambrisentan

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

mavacamten

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

tranylcypromine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

progesterone

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

hydroxybupropion

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

dexlansoprazole

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

nebivolol

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

leflunomide

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

rivaroxaban

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

n-desmethylclozapine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

labetalol

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

3,4-methylenedioxymethamphetamine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

proguanil

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

troglitazone

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

nelfinavir

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

desvenlafaxine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

hydromorphone

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

4-hydroxytamoxifen

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

fluconazole

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

ticlopidine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

sulfonamides, urea derivatives

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

amoxicillin

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

endoxifen

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

tolbutamide

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

trimipramine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

esomeprazole

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

ketoconazole

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

diazepam

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

N-desmethyltamoxifen

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

clobazam

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

doxepin

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

pantoprazole

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

mirtazapine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

carvedilol

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

imipramine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

mephenytoin

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

phenobarbital

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

atomoxetine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

antineoplastic agents

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

rabeprazole

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

lansoprazole

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

ibuprofen

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

prasugrel

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

clomipramine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

desipramine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

duloxetine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

celecoxib

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

rosuvastatin

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

quetiapine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

acenocoumarol

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

fluvoxamine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

amitriptyline

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

nortriptyline

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

bupropion

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

escitalopram

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

voriconazole

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

sertraline

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

omeprazole

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

valproic acid

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

venlafaxine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

fluoxetine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

paroxetine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

methadone

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

antidepressants

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

atorvastatin

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

citalopram

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

clozapine

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

aspirin

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

cyclophosphamide

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

tamoxifen

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

efavirenz

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

phenytoin

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

clopidogrel

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

tacrolimus

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Chemical

warfarin

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Genes

Haplotype

CYP2C19*1

and

Gene

CYP2C19

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Diseases

Haplotype

CYP2C19*1

and

Disease

Granulomatous Disease, Chronic

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Heartburn

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Shock, Septic

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Pharyngitis

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

eosinophilic esophagitis

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Respiratory Tract Infections

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Gastric pH

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Cerebrovascular Disorders

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Coronary Restenosis

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Ulcer

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Hematologic Disorder

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

adverse cardiovascular events

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

platelet aggregation inhibition

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Hallucinations

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Suicide

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Carcinoma, Squamous Cell

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

platelet aggregation

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Peripheral Vascular Diseases

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Carotid Artery Diseases

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Mycoses

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

high on-treatment platelet reactivity

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Alcohol-Related Disorders

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Hyperprolactinemia

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Esophagitis

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Edema

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Seizures

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Metabolic Syndrome

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Autism

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

platelet reactivity

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Panic Disorder

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Treatment failure

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Recurrence free survival

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Inflammation

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Schizoaffective disorder

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Peptic Ulcer Disease

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Major Adverse Cardiac Events (MACE)

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Transient Ischemic Attack

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Cardiotoxicity

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Non-Hodgkin Lymphoma

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Angina Pectoris

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Acquired Long QT Syndrome (aLQTS)

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Recurrence

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Lymphoma

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Discontinuation

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Obsessive-Compulsive Disorder

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Infectious disease

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Thrombotic disease

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Helicobacter Infections

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Anxiety Disorders

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Gastroesophageal Reflux

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Malaria

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Pancreatic Neoplasms

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Death

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Atrial Fibrillation

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Exanthema

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

event-free survival

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Coronary Disease

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Mental Disorders

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Psychotic Disorder

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Hepatitis C virus infection

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Vomiting

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

overall survival

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Hypercholesterolemia

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Nausea

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Stroke

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Hemorrhage

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Bipolar Disorder

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Attention Deficit Disorder with Hyperactivity

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Myocardial Infarction

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Lung transplantation

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Depressive Disorder

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Hematopoietic stem cell transplantation

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Acute coronary syndrome

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

adverse events

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Alcohol abuse

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Opioid-Related Disorders

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Diabetes Mellitus, Type 2

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Coronary Artery Disease

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Depression

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Cystic Fibrosis

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Toxic liver disease

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Rheumatoid arthritis

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Tobacco Use Disorder

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Asthma

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Cardiovascular Disease

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Epilepsy

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Acute lymphoblastic leukemia

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Kidney Transplantation

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Major Depressive Disorder

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Schizophrenia

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Breast Neoplasms

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Drug Toxicity

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature

Haplotype

CYP2C19*1

and

Disease

Neoplasms

Prescribing Info Label Annotation Clinical Annotation Variant Annotation Pathway Literature